Neurocrine Biosciences (NBIX) Reports In-Line Q3 EPS
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $152.93 -1.68%
Financial Fact:
Deferred gain on real estate: 853K
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Deferred gain on real estate: 853K
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q3 EPS of ($0.21), in-line with the analyst estimate of ($0.21).
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Etsy upgraded to buy at BofA on durable growth, buyback potential
- Deere shares climb as fiscal Q3 earnings and revenue top estimates
- Ross Stores (ROST) Tops Q2 EPS by 72c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
